Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

  • Intake of specific carotenoids and lung cancer risk.
    L Le Marchand, J H Hankin, L N Kolonel, G R Beecher, L R Wilkens and L P Zhao
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 183-187;

  • Attributable risk for oral cancer in northern Italy.
    E Negri, C La Vecchia, S Franceschi and A Tavani
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 189-193;

  • Urinary excretion of nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for nasopharyngeal carcinoma in southern China.
    Z Yi, H Ohshima, G Bouvier, P Roy, J Zhong, B Li, I Brouet, G de Thé and H Bartsch
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 195-200;

  • Histopathological predictors of breast cancer death among Caucasians and Japanese in Hawaii.
    C M Higuchi, S A Serxner, A M Nomura and G N Stemmermann
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 201-205;

  • Human papillomaviruses and cervical neoplasia in South Carolina.
    A L Coker, G R Jenkins, M S Busnardo, J C Chambers, L Z Levine and L Pirisi
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 207-212;

  • Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii.
    D Shibata, D Hawes, G N Stemmermann and L M Weiss
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 213-217;

  • The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.
    G W Comstock, G B Gordon and A W Hsing
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 219-221;

  • Detection of mutagens in cervical mucus in smokers and nonsmokers.
    E A Holly, R D Cress, D K Ahn, D A Aston, J J Kristiansen, R Wu and J S Felton
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 223-228;

  • Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation.
    S Gupta-Burt, H Shamkhani, E Reed, R E Tarone, C J Allegra, L H Pai and M C Poirier
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 229-234;

  • Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.
    L Pendyala, P J Creaven and C W Porter
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 235-241;

  • Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humans.
    P J Creaven, L Pendyala and N J Petrelli
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 243-247;

  • Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers.
    I M Jones, D H Moore, C B Thomas, C L Thompson, C L Strout and K Burkhart-Schultz
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 249-260;

  • Predictors of long-term smoking cessation in head and neck cancer patients.
    E R Gritz, C R Carr, D Rapkin, E Abemayor, L J Chang, W K Wong, T R Belin, T Calcaterra, K T Robbins and G Chonkich
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 261-270;

  • PSK as a chemopreventive agent.
    H Kobayashi, K Matsunaga and M Fujii
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 271-276;

  • Risk factors for childhood brain tumors.
    R R Kuijten and G R Bunin
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 277-288;

  • Measurement of oxidative stress status in humans.
    W A Pryor
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 289-292;

  • Rising incidence of colon cancer in Shanghai.
    S S Devesa, F Jin, W Zheng, W J Blot, J F Fraumeni Jr and Y T Gao
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 293-294;

  • Position statement of the American Urological Association.
    Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 295-295;

Back to top
PreviousNext
May 1993
Volume 2, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Advertisement
  • Most Cited
  • Most Read
Loading
  • Pitfalls in Biomarker Discovery and Validation
  • Key Characteristics of Carcinogens: Assays and Biomarkers
  • Tumor DNA as a Cancer Biomarker
  • A Tale of Two Diverse Qualtrics Samples
  • Reductions in Deaths from Diagnosing Cancer Before Stage IV
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement